ROC curve analyses indicated that MCP-4/eotaxin-3 expression signature exhibited high AUC value in distinguishing COPD patients and healthy controls, with sensitivity of 79.22/82.64% and specificity of 71.29/69.43%, respectively (Figures 1(e) and 1(f)). The gene discussed is CCL13; the disease is chronic obstructive pulmonary disease.